3,688
edits
TYK56: Difference between revisions
no edit summary
m (1 revision imported) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
The halogenated volatile anesthetic agents decrease alveolar ventilation mainly through which of the following mechanisms? | The halogenated volatile anesthetic agents decrease alveolar ventilation mainly through which of the following mechanisms? | ||
| Line 10: | Line 9: | ||
D. Decreased airway musculature tone | D. Decreased airway musculature tone | ||
<div class="mw-customtoggle-TYK_Answer" style="text-align: right; color:#0000ff">Click for Answer</div> | |||
<div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-TYK_Answer"> | |||
<div class="mw-collapsible- | |||
==Answer== | ==Answer== | ||
The answer is A. This a favorite question of Dr. Yaster. The halogenated agents (halothane, sevoflurane, isoflurane and desflurane) all depress the ventilatory drive and responsiveness to carbon dioxide in a dose dependent fashion. This is mainly done through a DECREASE IN TIDAL VOLUME. Respiratory rates tend to increase up to 1 MAC and then decrease at levels above 1 MAC. Decreased airway tone is an effect, but usually causes obstruction, not decreased alveolar ventilation. | The answer is A. This a favorite question of Dr. Yaster. The halogenated agents (halothane, sevoflurane, isoflurane and desflurane) all depress the ventilatory drive and responsiveness to carbon dioxide in a dose dependent fashion. This is mainly done through a DECREASE IN TIDAL VOLUME. Respiratory rates tend to increase up to 1 MAC and then decrease at levels above 1 MAC. Decreased airway tone is an effect, but usually causes obstruction, not decreased alveolar ventilation. | ||
==Notes== | ==Notes== | ||
<references /> | <references /> | ||
==Keywords== | ==Keywords== | ||
</div> | </div> | ||
---- | ---- | ||
---- | ---- | ||